1. Complete suspension culture of human induced pluripotent stem cells supplemented with suppressors of spontaneous differentiation
- Author
-
Mami Matsuo-Takasaki, Sho Kambayashi, Yasuko Hemmi, Tamami Wakabayashi, Tomoya Shimizu, Yuri An, Hidenori Ito, Kazuhiro Takeuchi, Masato Ibuki, Terasu Kawashima, Rio Masayasu, Manami Suzuki, Yoshikazu Kawai, Masafumi Umekage, Tomoaki M Kato, Michiya Noguchi, Koji Nakade, Yukio Nakamura, Tomoyuki Nakaishi, Naoki Nishishita, Masayoshi Tsukahara, and Yohei Hayashi
- Subjects
induced pluripotent stem cells ,suspension culture ,protein kinase C ,WNT ,bioreactor ,Medicine ,Science ,Biology (General) ,QH301-705.5 - Abstract
Human induced pluripotent stem cells (hiPSCs) are promising resources for producing various types of tissues in regenerative medicine; however, the improvement in a scalable culture system that can precisely control the cellular status of hiPSCs is needed. Utilizing suspension culture without microcarriers or special materials allows for massive production, automation, cost-effectiveness, and safety assurance in industrialized regenerative medicine. Here, we found that hiPSCs cultured in suspension conditions with continuous agitation without microcarriers or extracellular matrix components were more prone to spontaneous differentiation than those cultured in conventional adherent conditions. Adding PKCβ and Wnt signaling pathway inhibitors in the suspension conditions suppressed the spontaneous differentiation of hiPSCs into ectoderm and mesendoderm, respectively. In these conditions, we successfully completed the culture processes of hiPSCs, including the generation of hiPSCs from peripheral blood mononuclear cells with the expansion of bulk population and single-cell sorted clones, long-term culture with robust self-renewal characteristics, single-cell cloning, direct cryopreservation from suspension culture and their successful recovery, and efficient mass production of a clinical-grade hiPSC line. Our results demonstrate that precise control of the cellular status in suspension culture conditions paves the way for their stable and automated clinical application.
- Published
- 2024
- Full Text
- View/download PDF